Robert E. Marx, D.D.S., professor of surgery and chief of the Division of Oral and Maxillofacial Surgery, has been named the inaugural president of the Tissue Engineering Society. He was selected by the society's organizing committee in part for his pioneering work in the development of clinical applications for platelet rich plasma and recombinant human bone morphogenetic protein growth factor.

Arturo Loaiza-Bonilla, M.D., a fellow in the Division of Hematology-Oncology, has been appointed vice speaker of the AMA Residents and Fellows Section 2010-2011 Governing Council. The election was announced during the 2010 AMA annual meeting in Chicago, where Loaiza-Bonilla also received the Standing Committee Chair of the Year award for his work on the Committee on Scientific Research.

Susan Estabrooks Hahn, M.S., C.G.C., assistant director of communications, compliance and ethics at the John P. Hussman Institute for Human Genomics, was elected to the board of directors of the American Board of Genetic Counseling (ABGC). A credentialing organization for the genetic counseling profession in the United States and Canada, the ABGC establishes the standards of competence for clinical practice through the accreditation of graduate training programs and certification and recertification of genetic counselors.

Philip D. Harvey, Ph.D., professor of psychiatry and behavioral sciences, was re-elected to the board of directors of the Schizophrenia International Research Society and appointed to the scientific council of the National Association for Research on Schizophrenia and Affective Disorders.

Sara Czaja, Ph.D., professor of psychiatry and behavioral sciences, received a $49,988 grant from the AT&T Foundation to provide supplemental funding for a project that involves developing and implementing a tailored computer system for older adults who live alone and are at risk for isolation. The project is in the Center for Research and Education on Aging and Technology Enhancement (CREATE), funded by NIH. Dr. Czaja is the principal investigator on the project.

Thomas R. Van De Water, Ph.D., professor of otolaryngology and director of the Cochlear Implant Research Center, was awarded the rank of Fellow by the American Association of Anatomists (AAA) at the Experimental Biology Meeting in Anaheim, California. This honor recognizes members who have demonstrated excellence in science and in their overall contributions to the anatomical sciences.

Marjana Tomic-Canic, Ph.D., professor of dermatology and cutaneous surgery, received the Helen and Martin Kimmel Scientific Achievement Award during a wound healing educational meeting held in July. The award is given to an individual who has dedicated his or her career to using laboratory research to facilitate healing in the elderly, diabetics and others with chronic wounds.

M. Judith Donovan Post, M.D., professor of radiology, neurological surgery and ophthalmology, was an invited speaker at the 48th annual meeting of the American Society of Neuroradiology held in Boston in May. She spoke at the Spine Maintenance of Certification review session.

Mauro Moscucci, M.D., M.B.A., professor and vice chair of medicine and chief of the Cardiovascular Division, published a study in the August issue of the Journal of the American College of Cardiology: Cardiovascular Interventions that identified the prevalence and risk factors of retroperitoneal hematoma following an angioplasty procedure. The data was compiled from a pool of more than 112,000 patients who were part of the Blue Cross Blue Shield of Michigan Cardiovascular Consortium Registry, and represents the largest reported experience of retroperitoneal hematoma. Moscucci is currently consulting co-chair of the consortium, which he developed in 1997.

Mauricio G. Cohen, M.D., associate professor of medicine, published findings in the July 26 online issue of Circulation from a Phase IIa study of REG1, a unique RNA drug system made up of an anticoagulant/blood thinner (RB006) and a control agent (RB007) to reverse anticoagulation. The REG1 system is the first of its kind to enter clinical testing. The Phase IIa multi-site randomized study compared REG1 with unfractionated heparin during angioplasty.